To the Editor: Following a retrospective review of New South Wales data, Smith and colleagues concluded that the better long-term survival outcomes following surgery for oesophagogastric cancer at higher-volume centres support surgery only being done at these centres.1 However, much missing data creates uncertainty about this conclusion.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Smith RC, Creighton N, Lord RV, et al. Survival, mortality and morbidity outcomes after oesophagogastric cancer surgery in New South Wales, 2001–2008. Med J Aust 2014; 200: 408-413. <MJA full text>
- 2. Smyth E, Schöder H, Strong VE, et al. A prospective evaluation of the utility of 2-deoxy-2-[18F]fluoro-D-glucose positron emission topography and computed tomography in staging locally advanced gastric cancer. Cancer 2012; 118: 5481-5488.
- 3. Hategan M, Cook N, Prewett S, et al. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature. Dis Esophagus 2014; May 27 [Epub ahead of print].
- 4. Kersten C, Cvancarova M, Mjåland S, Mjåland O. Does in-house availability of multidisciplinary teams increase survival in upper gastrointestinal-cancer? World J Gastrointest Oncol 2013; 5: 60-67.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.